期刊文献+

大剂量阿托伐他汀对非ST段抬高型心梗后心功能的影响 被引量:1

Effect of high dose of atorvastatin on heart function of patients with non-ST elevation myocardial infarction
暂未订购
导出
摘要 目的观察大剂量阿托伐他汀强化治疗对NSTE-AMI患者心功能的影响。方法 74例NSTE-AMI患者随机分为阿托伐他汀常规治疗组(20 mg/晚)及强化治疗组(40 mg/晚),超声测量治疗24 h内及3个月后左室射血分数(LVEF)及左室舒张末内径(LVEDd),并于24 h内、3个月测定血浆NT-proBNP。结果两组患者LVEF、LVEDd及NT-proBNP在治疗3个月后与治疗24 h内比较差异有统计学意义(P<0.05),强化治疗组LVEF较常规治疗组升高更明显,LVEDd则进一步下降,血浆NT-proBNP亦进一步下降。结论大剂量阿托伐他汀较常规剂量治疗NSTE-AMI心力衰竭可以进一步提高心功能,改善预后。 Objective To explore the effect of high dose of atorvastatin on changes of left ventricular function in patients with acute non ST elevation myocardial infarction (NSTE-AMI) randomly. Methods Seventy-four cases of NSTE-AMI pa- tients were devided into conventional treatment group (atorvastatin 20 mg/d) and intensive treatment group (atorvastatin 40 rag/d), left ventricular ejection fraction (LVEF) and left ventricular end diastolic diameter(LVEDd) were measured by ul trasound after 24 hours and 3 months treated, and plasma level of NT-pro brain natriuretic peptide (NT-proBNP) were measured at the same time. Results There were significant differences in the levels of LVEDd,LVEF and NT-proBNP be tween the conventional treatment group and the intensive treatment group after 3 month treatment (P 〈 0.05). LVEF in the intensive treatment group was higher than in the conventional treatment group but LVEDd was the reversed,plasma NT- proBNP decreased in the intensive treatment group more significantly than in the other (P 〈 0.05). Conclusion High dose of atorvastatin can improve heart function and improve the long-term prognosis in NSTE-AMI patients.
作者 胡松
出处 《中国现代医生》 2012年第29期76-78,共3页 China Modern Doctor
关键词 阿托伐他汀 非ST段抬高型心梗 心功能 Atorvastatin Non-ST elevation acute myocardial infarction Heart function
  • 相关文献

参考文献8

二级参考文献40

  • 1黄伟光,韦建瑞,吴同果,陈思伟,孙爱华,梅克治.冠心病病人N端前脑钠肽检测的临床意义[J].岭南心血管病杂志,2007,13(5):337-339. 被引量:14
  • 2方臻飞,周胜华,胡信群,沈向前,祁述善.急性冠状动脉综合征患者冠状动脉循环粘附分子的变化[J].中国动脉硬化杂志,2005,13(2):215-217. 被引量:24
  • 3李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 4Hayashidani S, Tsutsui H, Shiomi T, et al. Fluvastatin, a 3- hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction[J]. Circulation, 2002, 105(7): 868-873.
  • 5Brower GL, Janieki JS. Contribution of ventricular remodeling to pathogenesis of heart failure in rats [ J]. Am J Physiol Heart Circ Physiol, 2001, 280(2): H674- H683.
  • 6Laufs U, Kilter H, Konkol C, et al. hnpact of HMG CoA reductase inhibition on small GTPases in the heart [ J ]. Cardiovasc Res, 2002, 53(4) : 911 -920.
  • 7Calabro P, Yeh ET. The pleiotropic effects of statins[ J]. Curr Opin Cardiol, 2005, 20(6): 541 -546.
  • 8Ramasubbu K, Mann DL. The emerging role of statins in the treatment of heart failure[J]. J Am Coll Cardiol, 2006, 47(2) : 342 - 344.
  • 9Node K, Fujita M, Kitakaze M, et al. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy [ J ]. Circulation, 2003, 108 ( 7 ) : 839 - 843.
  • 10Mozaffarian D, Nye R, Levy WC. Statin therapy is associated with lower mortality among patients with severe heart failure [ J ]. Am J Cardiol, 2004, 93(9): 1124- 1129.

共引文献2251

同被引文献8

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部